“…In addition, YQFM can regulate MAPKs and alleviate myocardial remodeling and heart failure caused by coronary artery ligation (CAL) ( Pang et al, 2017 ). Many components of YQFM show mitochondrial regulation ( Zheng et al, 2018 ), including ginsenosides Rb1, Rb3, Rg1, Rg3, Schisandra B, and ophiopogon D ( Chiu et al, 2007 ; Chen and Ko, 2010 ; Sun et al, 2013 ; Mu et al, 2015 ; Dong et al, 2016 ; Chen et al, 2019 ; Park et al, 2019 ; Li et al, 2021 ). Nevertheless, the mechanism of YQFM in treating chronic heart failure remains to be further elucidated.…”